https://www.selleckchem.com/products/arn-509.html
is considered in addition to the costs of diagnosis, staging, and treatment of screen-detected PCs. PSA screening is associated with significant costs to the health care system when the cost of the PSA test itself is considered in addition to the costs of diagnosis, staging, and treatment of screen-detected PCs. Prostate cancer (PC) is the most commonly diagnosed non-cutaneous cancer in men and their second or third leading cause of cancer death. Prostate-specific antigen (PSA) testing for PC has been in common practice for more than 20
Like
Comment
Share
